Our Team

Find out more about our exceptional team here at Align Strategy. With extensive expertise in the pharmaceutical industry, our consultants are here to support you on your strategy development journey.

Christine Fletcher

Managing Director

Christine, co-founder of Align Strategy, advises top pharmaceutical companies on competitive and brand strategy with over 20 years of experience.

Qualifications

BA, Economics (Tufts University)

Neal Hansen, PhD

Managing Director

As co-founder of Align Strategy, Neal brings over 20 years of experience advising leading pharmaceutical and biotech firms on lifecycle management and brand strategy.

Qualifications

PhD, Pharmacology (University of Cambridge)

MA (Hons), Natural Sciences (University of Cambridge)

Ania Freiha, MPH

Director

Ania, with over 12 years in healthcare consulting, excels in strategic planning and lifecycle management for pharmaceutical clients.

Qualifications

BS, Metabolic and Nutritional Sciences (Boston University)

MPH, Dual specialization in Health Policy & Management and Pharmaceutical Assessment, Policy, & Management (Boston University)

Andrew Heron, PhD

Director

Andrew has 20+ years experience and specializes in leading strategic projects at brand and franchise levels.

Qualifications

PhD, Chemistry (University of Glasgow)

BSc (Hons), Medicinal Chemistry (University of Glasgow)

Taahira Faruque

Principal Consultant

Taahira, with 6+ years in Life Sciences, specializes in commercial strategy, focusing on brand strategy across various disease areas.

Qualifications

BSc (Hons), Neuroscience (University of Nottingham, UK)

Laura Gabarró

Principal Consultant

Laura has over a decade of experience in pharmaceutical consultancy, specializing in primary research and strategic planning.

Qualifications

BA, Business Management and Administration(Universitat Pompeu Fabra)

Brianna Hewson

Principal Consultant

Brianna, with a decade in healthcare, aids strategic decision-making for leading pharmaceuticals, specializing in launch and lifecycle strategy for early-stage assets.

Qualifications

MSc, Biotechnology and Enterprise (University of Manchester)

BSc, Biology (University of Massachusetts Amherst)

James Kettlewell

Principal Consultant

James, with nearly 10 years in healthcare, specializes in shaping strategic direction through product and market assessments.

Qualifications

MSc, Drug Discovery & Translational Biology (University of Edinburgh)

BSc, Cell Biology (University of St Andrews)

Jamie Plumer, PhD

Principal Consultant

Jamie supports top companies with insights and strategy, specializing in biosimilars and therapy areas like immunology, oncology, hematology, and epilepsy.